Licenced doses of approved COVID-19 vaccines may not be optimal: A review of the early-phase, dose-finding trials
Description
Although over 13 billion COVID-19 vaccine doses have been administered globally, the issue of whether the optimal doses are being used has received little attention. To address this question we reviewed the reports of early-phase dose-finding trials
